2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theMajor Depressive Disorder Market?

The surge in instances of substance and alcohol misuse is anticipated to boost the expansion of the major depressive disorder industry. These terms refer to the overuse or harmful use of things like alcohol, which results in detrimental physical, psychological, and societal repercussions. The likelihood of major depressive disorder is commonly heightened with substance or alcohol abuse, with both often exacerbating the impacts of the other, thereby elevating the risk of harm, both mentally and physically. As an example, statistics released in July 2024 from the Substance Abuse and Mental Health Services Administration, a department of health and human services in the US, stated that 3.1% of individuals, or 8.9 million people, misused opioids in 2023, and 21.8% of individuals 12 or older used marijuana, the most frequently used illegal drug. Furthermore, it was noted that 9.4% of people 12 or older had recently vaped nicotine, an increase from the 8.3% in 2022. As a result of these escalating rates of substance and alcohol abuse, the major depressive disorder industry is growing. The major depressive disorder market is also being fuelled by the escalating number of anxiety cases. Anxiety, characterised by fear, dread, and uneasiness, is a common reaction to stress, often resulting in excessive concern about everyday events. Because anxiety can lead to nervousness, irritability, and issues with sleep and concentration, it significantly contributes to major depressive disorder. Furthermore, figures from the American Psychiatric Association, a not-for-profit organization in the US, revealed in May 2024 that 43% of adults confessed to experiencing increased anxiety compared to the previous year, an uptick from 37% in 2023 and 32% in 2022. Therefore, the increasing occurrences of anxiety are driving the expansion of the major depressive disorder market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13042&type=smp

#How Does the ProjectedMajor Depressive Disorder Market Growth Compare Over the Forecast Period?

The market size for major depressive disorder has been gradually increasing over the recent years. The market is projected to expand from $6.12 billion in 2024 to $6.28 billion in 2025, with a compound annual growth rate (CAGR) of 2.6%. The growth observed during the historical period can be linked to advancements in pharmaceuticals, increased consciousness about mental health, psychological treatments, and public health campaigns.

Anticipated steady growth is predictable for the major depressive disorder market in the coming years. The market size is projected to expand to the value of $7.13 billion by 2029, with a compound annual growth rate (CAGR) of 3.2%. This expected growth during the forecast period is primarily influenced by factors such as precision medicine, telepsychiatry and teletherapy, innovative treatment models, and the worldwide expansion of mental health services. Essential trends for the forecast period encompass early intervention, peer support augmented by online communities, comprehensive methodologies, resilience, and coping mechanisms.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13042

Which Upcoming Market Trends and Innovations Are Set to Influence theMajor Depressive Disorder Market’s Path Forward?

Leading companies in the machinery and industrial automation market are starting to concentrate more on the production of industrial automation products to raise their profitability margin. These products encompass a variety of technological advancements and apparatus built to streamline and enhance industrial operations. For instance, Renishaw Inc., a company from the UK that operates in the machine industry, introduced a fresh line of industrial automation products in May 2023. This product line comprises three distinct items, namely RCS L-90, RCS T-90, and RCS P-series, all complemented by a customized software suite. The recently launched RCS product line seeks to tackle prevalent issues in the global industrial automation sector, specifically focusing on manual setup, robot calibration, and maintenance. The RCS L-90 is a ball-bar device that boosts the precision of the robot system, decreases setup time, and keeps a check on the health of the robot. Similarly, RCS T-90 is a tri-ball bar system that empowers users to detect the underlying reasons for subpar performance and gather crucial information about the robot.

Who Are the Dominant Market Players Pushing the Boundaries of theMajor Depressive Disorder Market?

Major companies operating in the major depressive disorder market are Pfizer Inc., Janssen Research And Development LLC, Merck and Co. Inc., Novartis AG, Sanofi-Aventis US LLC, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Biogen Inc., Otsuka Pharmaceuticals Co.Ltd., Forest Laboratories Inc., H. Lundbeck A/S, Richter Gedeon PLC, Allergan PLC, Neurocrine Biosciences Inc., BlackThorn Therapeutics Inc., Intra-Cellular Therapies Inc., Axsome Therapeutics Inc., Luye Pharma Group, BioLite Inc., BrainsWay Ltd., Neumora Therapeutics Inc., Chase Therapeutics Corporation, SAGE Therapeutics Inc., Arrivo Bioventures LLC, Relmada Therapeutics Inc., Fabre-Kramer Pharmaceuticals Inc., Vistagen Therapeutics Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report

What Are the Core Segments of the Major Depressive Disorder Market, and How Do They Contribute to Growth?

The major depressive disorder market covered in this report is segmented –

1) By Treatment: Psychotherapy, Medications, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Other Treatments

2) By Diagnosis: Physical Examinations, Laboratory Tests, Psychiatric Evaluations, Diagnostic And Statistical Manual of Mental Disorders (DSM-5), Other Diagnosis

3) By End-User: Clinics, Hospitals, Other End-Users

Subsegments:

1) By Psychotherapy: Cognitive Behavioral Therapy (CBT), Interpersonal Therapy (IPT), Dialectical Behavior Therapy (DBT), Psychodynamic Therapy

2) By Medications: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs), Monoamine Oxidase Inhibitors (MAOIs), Atypical Antidepressants

3) Electroconvulsive Therapy (ECT): Unilateral ECT, Bilateral ECT, Modified ECT

4) Transcranial Magnetic Stimulation (TMS): Repetitive Transcranial Magnetic Stimulation (rTMS), Deep Transcranial Magnetic Stimulation (dTMS), Theta Burst Stimulation (TBS), Navigated Brain Stimulation (nTMS)

5) Other: Cognitive Behavioral Therapy (CBT), Psychodynamic Therapy, Interpersonal Therapy (IPT), Vagus Nerve Stimulation (VNS), Ketamine Therapy, Bright Light Therapy, Psychedelic-Assisted Therapy, Medication (Antidepressants)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13042&type=smp

What Regions Are Dominating the Major Depressive Disorder Market Growth?

North America was the largest region in the major depressive disorder market in 2024. The regions covered in major depressive disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Major Depressive Disorder Market 2025, By The Business Research Company:

Residential Substance Abuse And Mental Health Facilities Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report

Mental Health Apps Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mental-health-apps-global-market-report

Telepsychiatry Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: